Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
898 Ergebnisse
| GW9FEZ | Regeneron Pharmaceuticals Inc./OS/Call [630]/GOLDS | - | - | 630,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,038 % | 0,684 | -0,009 | 2,666 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW9CYX | Regeneron Pharmaceuticals Inc./OS/Call [640]/GOLDS | - | - | 640,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,129 % | 0,673 | -0,009 | 2,692 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW9CYY | Regeneron Pharmaceuticals Inc./OS/Call [640]/GOLDS | - | - | 640,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,315 % | 0,684 | -0,008 | 2,409 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW9D0L | Regeneron Pharmaceuticals Inc./OS/Call [640]/GOLDS | - | - | 640,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,702 % | 0,661 | -0,011 | 3,430 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| JF9RFX | Regeneron Pharmaceuticals Inc./OS/Call [640]/JPM | - | - | 640,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,165 % | 0,658 | -0,015 | 4,995 | 18.12.2026 | 0,010 | JP Morgan | ||
| JH48W9 | Regeneron Pharmaceuticals Inc./OS/Call [640]/JPM | - | - | 640,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,499 % | 0,679 | -0,022 | 7,433 | 18.09.2026 | 0,010 | JP Morgan | ||
| JE9D3K | Regeneron Pharmaceuticals Inc./OS/Call [640]/JPMD | - | - | 640,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,864 % | 0,657 | -0,014 | 4,685 | 15.01.2027 | 0,010 | JP Morgan | ||
| JE9D5Q | Regeneron Pharmaceuticals Inc./OS/Call [640]/JPMD | - | - | 640,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,784 % | 0,654 | -0,013 | 3,908 | 19.03.2027 | 0,010 | JP Morgan | ||
| JY1K0P | Regeneron Pharmaceuticals Inc./OS/Call [640]/JPMD | - | - | 640,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,565 % | 0,700 | -0,031 | 9,008 | 21.08.2026 | 0,010 | JP Morgan | ||
| PG10X0 |  | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,109 % | 0,632 | -0,016 | 4,930 | 18.12.2026 | 0,010 | BNP Paribas | |
| PG10X5 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,999 % | 0,635 | -0,015 | 4,588 | 15.01.2027 | 0,010 | BNP Paribas | |
| PG10XH | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,287 % | 0,642 | -0,024 | 7,455 | 18.09.2026 | 0,010 | BNP Paribas | |
| PJ912P | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,684 % | 0,638 | -0,013 | 3,982 | 19.03.2027 | 0,010 | BNP Paribas | |
| PK0118 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,520 % | 0,662 | -0,009 | 2,685 | 17.12.2027 | 0,010 | BNP Paribas | |
| PM3TMA | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,627 % | 0,647 | -0,011 | 3,361 | 17.06.2027 | 0,010 | BNP Paribas | |
| PM3TMC | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,698 % | 0,665 | -0,009 | 2,608 | 21.01.2028 | 0,010 | BNP Paribas | |
| PM3TMD | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,953 % | 0,671 | -0,009 | 2,500 | 17.03.2028 | 0,010 | BNP Paribas | |
| PM3TME | | Regeneron Pharmaceuticals Inc./OS/Call [650]/BNP | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 46,843 % | 0,679 | -0,008 | 2,337 | 16.06.2028 | 0,010 | BNP Paribas | |
| GW1T95 | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,124 % | 0,663 | -0,009 | 2,722 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW3WD7 | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,682 % | 0,635 | -0,014 | 4,819 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW4K3R | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,567 % | 0,639 | -0,012 | 4,156 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW92PH | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,503 % | 0,674 | -0,008 | 2,463 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW92TJ | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,045 % | 0,645 | -0,011 | 3,528 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW92TM | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 35,528 % | 0,645 | -0,022 | 8,124 | 18.09.2026 | 0,010 | Goldman Sachs | ||
| GN0FY1 | Regeneron Pharmaceuticals Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | 750,000 | - | - | - | - | 18.09.2026 | 0,100 | Goldman Sachs | ||
| JF9RFZ | Regeneron Pharmaceuticals Inc./OS/Call [650]/JPM | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,590 % | 0,633 | -0,015 | 5,203 | 18.12.2026 | 0,010 | JP Morgan | ||
| JH48WB | Regeneron Pharmaceuticals Inc./OS/Call [650]/JPM | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,313 % | 0,646 | -0,022 | 7,964 | 18.09.2026 | 0,010 | JP Morgan | ||
| MK21H9 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,167 % | 0,630 | -0,016 | 4,838 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MK9KFD | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,238 % | 0,646 | -0,011 | 3,327 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM5GYT | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,390 % | 0,632 | -0,026 | 7,049 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN1W1T | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | 700,000 | - | - | - | - | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN8XD9 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | 700,000 | - | - | - | - | 20.11.2026 | 0,100 | Morgan Stanley | |
| MN8XDA | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | 700,000 | - | - | - | - | 18.12.2026 | 0,100 | Morgan Stanley | |
| MN8XD8 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | 700,000 | 5,222 % | - | - | - | 19.03.2027 | 0,100 | Morgan Stanley | |
| MN9V78 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,541 % | 0,637 | -0,013 | 3,925 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR03TD | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 48,061 % | 0,663 | -0,010 | 2,583 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MR3CEZ | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 53,997 % | 0,688 | -0,009 | 2,120 | 16.06.2028 | 0,010 | Morgan Stanley | |
| MR3SHJ | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | 700,000 | 5,248 % | - | - | - | 15.01.2027 | 0,100 | Morgan Stanley | |
| MR3SQ4 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/MS | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | 700,000 | 5,230 % | - | - | - | 17.06.2027 | 0,100 | Morgan Stanley | |
| FA6MCU | Regeneron Pharmaceuticals Inc./OS/Call [650]/SOC | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,722 % | 0,640 | -0,235 | 7,565 | 18.09.2026 | 0,100 | Société Générale | ||
| FA6MCW | Regeneron Pharmaceuticals Inc./OS/Call [650]/SOC | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,789 % | 0,631 | -0,153 | 5,076 | 18.12.2026 | 0,100 | Société Générale | ||
| FD5FE3 | Regeneron Pharmaceuticals Inc./OS/Call [650]/SOC | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,593 % | 0,636 | -0,124 | 4,079 | 19.03.2027 | 0,100 | Société Générale | ||
| VY416D | | Regeneron Pharmaceuticals Inc./OS/Call [650]/VONT | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,041 % | 0,634 | -0,014 | 4,687 | 15.01.2027 | 0,010 | Vontobel | |
| VY419S | | Regeneron Pharmaceuticals Inc./OS/Call [650]/VONT | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,718 % | 0,650 | -0,035 | 9,159 | 21.08.2026 | 0,010 | Vontobel | |
| VY42D5 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/VONT | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,725 % | 0,631 | -0,016 | 4,978 | 18.12.2026 | 0,010 | Vontobel | |
| VY5LQ6 | | Regeneron Pharmaceuticals Inc./OS/Call [650]/VONT | - | - | 650,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,890 % | 0,637 | -0,024 | 7,393 | 18.09.2026 | 0,010 | Vontobel | |
| GW0VJM | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,368 % | 0,632 | -0,011 | 3,494 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW0VKX | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,375 % | 0,619 | -0,012 | 4,261 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW0VL0 | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,344 % | 0,614 | -0,014 | 4,974 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW1J1F | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,363 % | 0,648 | -0,009 | 2,863 | 17.12.2027 | 0,010 | Goldman Sachs |